During the G20 debates in the House of Lords, Baroness Ledford highlighted the growing threat that antimicrobial resistance represents to public health and economic development. She described how the G20 leaders had made various recommendations including a new research and development collaboration hub. She drew attention to the fact that more than 40,000 people a year in England die from sepsis, and that half of TB patients with resistance are in G20 countries. Baroness Evans of Bowes Park agreed but highlighted that research funding alone will not solve the problem and that the UK must, in parallel develop incentives for pharmaceutical companies to bring new drugs to market. The Baroness highlighted that the publication of the G20-commissioned report, “Tackling Antimicrobial Resistance, Ensuring Sustainable R&D“, means that there is a clear way forward, and that the Government have also committed £50 million towards a global AMR innovation fund, which will target investment in underinvested areas of research and development.